Medicare Enrolled

Dr. Balveen Singh, D.O.

Psychiatry · New City, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
216 CONGERS RD BLDG 3, New City, NY 10956
8454806678
In practice since 2010 (16 years)
NPI: 1164753745 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Singh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Singh? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Singh

Dr. Balveen Singh is a psychiatry specialist in New City, NY, with 16 years of NPI registration. Based on federal Medicare data, Dr. Singh performed 564 Medicare services across 211 unique beneficiaries.

Between the years covered by Open Payments, Dr. Singh received a total of $156,172 from 29 pharmaceutical and/or device companies across 710 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Singh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 25% volume in NY $156,172 industry payments

Medicare Practice Summary

Medicare Utilization ↗
564
Medicare services
Top 25% in NY for psychiatry
211
Unique beneficiaries
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~35 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
110 $68 $157
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
107 $118 $181
45-minute psychotherapy and evaluation visit
A 45-minute session that includes both psychotherapy and an evaluation and management visit.
96 $79 $180
Psychotherapy and evaluation, 30 minutes
A combined session involving psychotherapy and an evaluation and management visit lasting 30 minutes.
84 $60 $120
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
77 $78 $150
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
65 $98 $222
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
25 $41 $75
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$156,172
Total received (2018-2024)
Avg $22,310/year across 7 years
Top 1% in NY for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
710
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$118,182 (75.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$24,672 (15.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,318 (8.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$76,371
2023
$39,922
2022
$27,728
2021
$3,863
2020
$3,071
2019
$4,707
2018
$510

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Otsuka America Pharmaceutical, Inc.
$48,418
Axsome Therapeutics, Inc.
$24,672
Neuronetics, Inc.
$1,718
ABBVIE INC.
$455
Alkermes, Inc.
$269
Janssen Pharmaceuticals, Inc
$228
Neurocrine Biosciences, Inc.
$185
Almatica Pharma LLC
$117
Indivior Inc.
$106
Corium, LLC
$50
Lundbeck LLC
$48
Orexo US, Inc.
$44
E.R. Squibb & Sons, L.L.C.
$43
Boston Scientific Corporation
$16
Top 3 companies account for 98.0% of 2024 payments
All-time payments by company (2018-2024) ›
Otsuka America Pharmaceutical, Inc.
$118,332
Axsome Therapeutics, Inc.
$24,977
Alkermes, Inc.
$2,120
Neuronetics, Inc.
$1,745
Neurocrine Biosciences, Inc.
$1,392
Sunovion Pharmaceuticals Inc.
$1,336
Janssen Pharmaceuticals, Inc
$961
AbbVie Inc.
$926
ITI, Inc.
$909
ABBVIE INC.
$859
Lundbeck LLC
$649
Corium, LLC
$546
Allergan, Inc.
$260
Indivior Inc.
$209
Abbott Laboratories
$162
JAZZ PHARMACEUTICALS INC.
$147
Allergan Inc.
$128
Almatica Pharma LLC
$117
Otsuka Pharmaceutical Development & Commercialization, Inc.
$84
Teva Pharmaceuticals USA, Inc.
$52
Takeda Pharmaceuticals U.S.A., Inc.
$48
Orexo US, Inc.
$44
E.R. Squibb & Sons, L.L.C.
$43
BioXcel Therapeutics, Inc.
$25
Avanir Pharmaceuticals, Inc.
$22
PFIZER INC.
$22
Neos Therapeutics, LP
$21
Alfasigma USA, Inc.
$18
Boston Scientific Corporation
$16
Top 3 companies account for 93.1% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Aristada 441 mg · Auvelity · Azstarys · CAPLYTA · COBENFY · IGALMI · INGREZZA · INVEGA SUSTENNA · LATUDA · LOREEV XR · LYBALVI · NEUROSTAR TMS THERAPY SYSTEM · NUEDEXTA · PAXLOVID · PERSERIS · REXULTI · SPRAVATO · SUNOSI · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TRINTELLIX · VIVITROL · VRAYLAR · Vivitrol · Zubsolv
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (76%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in psychiatry and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for psychiatry in NY.

Looking for a psychiatry specialist in New City?
Compare psychiatrists in the New City area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists within 10 mi
1,571
Per 100K population
463.5
County median income
$110,631
Nearest hospital
HELEN HAYES HOSPITAL
4.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Singh is a clinical cardiology specialist, with above-average Medicare volume (top 25% in NY), with speaking/promotional industry engagement in the top 1% of NY peers, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Singh experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Singh performed 110 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Singh receive payments from pharmaceutical companies?
Yes. Dr. Singh received a total of $156,172 from 29 companies across 710 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Singh's costs compare to other psychiatrists in New City?
Dr. Singh's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Singh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →